Sun Y, Zhang K, Qi H, et al. Computational Predicting the Human Infectivity of H7N9 Influenza Viruses Isolated from Avian Hosts. ransbound Emerg Dis. 2020;10.1111/tbed.13750
The genome composition of a given avian influenza virus is the primary determinant of its potential for cross-species transmission from birds to humans. Here we introduce a viral genome-based computational tool that can be used to evaluate the human infectivity of avian isolates of influenza A H7N9 viruses, which can enable prediction of the potential risk of these isolates infecting humans. This tool, which is based on a novel class weight-biased logistic regression (CWBLR) algorithm, uses the sequences of the eight genome segments of an H7N9 strain as the input and gives the probability of this strain infecting humans (reflecting its human infectivity). We used the CWBLR model to examine the replication efficiency and pathogenicity of several H7N9 avian isolates that were predicted to have very low or high human infectivity in cell culture and in mice, and found that the strains with high predicted human infectivity replicated more efficiently in mammalian cells and were more infective in mice than those that were predicted to have low human infectivity. These results demonstrate that our CWBLR model can serve as a powerful tool for predicting the human infectivity and cross-species transmission risks of H7N9 avian strains.
See Also:
Latest articles in those days:
- Host Species Contribution to the Spatiotemporal Dynamics of the 2024-2025 H5N1 Epidemic in Italy 13 hours ago
- mRNA-based influenza vaccine expands the B cell response breadth in humans 13 hours ago
- Molecular surveillance and predictive risk modelling of avian influenza virus in wild birds in Egypt 13 hours ago
- Germany as a key transit hub for the emergence and spread of high pathogenicity avian influenza H5 clade 2.3.4.4b reassortants in Europe 2 days ago
- Degradation of ACSL3 by influenza A virus shifts unfolded protein response from antiviral defense to viral evasion 2 days ago
[Go Top] [Close Window]


